MIR stock forecast, quote, news & analysis
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience... Show more
Mirion Technologies (MIR) Stock Analysis: Nuclear Order Surge and Backlog Conversion Power a Rebound
Key Takeaways
- Mirion Technologies (MIR) shares have advanced roughly 9% over the trailing 30 days, moving from about $16.27 to approximately $17.73 as of early November 2026.
- Third-quarter 2026 revenue rose 24.5% year over year to $277.8 million, with organic growth of 6.5%.
- Nuclear power end-market orders climbed 105% year over year, helping drive total orders excluding M&A up 62%.
- Management raised full-year 2026 guidance, including total revenue growth of 24% to 25% and organic growth of 7% to 8%.
- Total backlog reached roughly $1.25 billion versus $816 million a year earlier, improving near-term revenue visibility.
- Adjusted EPS of $0.12 matched consensus, while adjusted EBITDA of $64.8 million came in below some estimates on acquisition dilution and AI-related spending.
- For additional detail, explore Mirion's Price Targets, Earnings, and Forecast pages for deeper data on valuation and expectations.
- Investors tracking automated trading strategies can also review Trending AI Robots for relevant market signals.
Current Market Snapshot
Mirion Technologies has traded in a volatile but ultimately constructive range through the second half of 2026. After slipping toward the low-$14 level in late September, the stock staged a sharp rebound following its late-October earnings report, climbing through the high-$18 range before settling near $17.73 in early November. The roughly 9% trailing 30-day advance still leaves shares well below their 52-week high, reflecting a stock that has recovered momentum but remains below prior peaks. Broader investor attention has centered on accelerating demand in the nuclear power sector, the conversion of a rapidly expanding order backlog into revenue, and management's ongoing investments in artificial intelligence and cybersecurity.
Mirion Technologies (MIR) Business Overview and Competitive Position
Mirion Technologies is a global provider of radiation detection, measurement, analysis, and monitoring solutions across two segments: Nuclear & Safety and Medical. The Nuclear & Safety business serves nuclear power plants, research laboratories, defense, and other industrial markets, supplying instrumentation, software, and services across a reactor's full lifecycle. The Medical segment focuses on radiation therapy quality assurance, nuclear medicine, and occupational dosimetry. Headquartered in Atlanta, Georgia, the company employs approximately 3,200 people and operates across 12 countries.
A key competitive advantage is Mirion's presence in more than 98% of the world's nuclear reactors, with roughly 80% of its nuclear power revenue tied to the existing operating fleet. That installed base positions the company to benefit from lifecycle extensions, power uprates, and digital instrumentation upgrades without depending solely on new reactor construction timelines. Investors follow MIR closely as a leveraged play on the nuclear energy revival and the associated data-center-driven demand for power generation.
Recent Developments Driving MIR
Mirion's third-quarter 2026 results, released in late October, supplied the primary catalyst for the stock's recent move. Revenue increased 24.5% to $277.8 million, and organic growth of 6.5% marked an inflection from the first half. The standout metric was order intake: nuclear power orders rose 105% year over year, while orders excluding M&A grew 62%. Total orders reached $386 million including the Paragon and Certrec contributions.
Management raised its full-year outlook, lifting total revenue growth guidance to 24% to 25% and organic growth to 7% to 8%, with fourth-quarter organic revenue expected to grow in the mid-to-high teens. Adjusted free cash flow guidance was also raised to $170 million to $185 million. At the same time, the company said it no longer considers its prior 2028 margin target achievable, citing tempered medical growth, Paragon integration, and deliberate investments in AI and cybersecurity that are pressuring near-term margins.
Capital allocation has also been active. Mirion repurchased $56 million of stock in the quarter, completed its initial $100 million buyback program, and established a new $250 million authorization. Management expects net leverage to improve to roughly 2.6x by year-end.
Trending AI Robots
Tickeron operates a broad suite of AI-powered trading bots that monitor thousands of tickers across numerous strategies and timeframes. The Trending AI Robots section curates only the top-performing and most relevant bots, giving traders a focused view of strategies that are currently standing out. Because these bots vary in approach, holding period, and performance metrics, the page offers a way to compare different automated signals rather than a one-size-fits-all recommendation. Investors interested in complementing their own analysis with data-driven automation may find it a useful starting point.
2026 Outlook and What Investors Should Watch
Heading into the remainder of 2026, the central theme for Mirion is whether record order momentum continues translating into accelerated revenue. Management has signaled mid-to-high teens organic growth for the fourth quarter, supported by backlog conversion and nuclear power demand from installed-base spending, life extensions, power uprates, and small modular reactor programs. Investors will also watch large project awards, including orders tied to Department of Energy contracts and European newbuild activity awaiting funding approval.
Margin trajectory remains a key point of scrutiny. Acquisition dilution from Paragon and Certrec, combined with rising AI and cybersecurity spending, has tempered near-term profitability even as revenue accelerates. How quickly those investments yield customer-facing product benefits will shape the earnings outlook. Macroeconomic factors, interest-rate expectations, and the pace of utility capital spending also matter, given Mirion's exposure to the nuclear and industrial end markets. Traders should monitor the next earnings release, updated guidance, and order-book disclosures for evidence that the current demand cycle is sustainable.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
MIR's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for MIR turned positive on October 28, 2026. Looking at past instances where MIR's MACD turned positive, the stock continued to rise in 40 of 53 cases over the following month. The odds of a continued upward trend are 75%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on MIR as a result. In 71 of 95 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
MIR moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for MIR crossed bullishly above the 50-day moving average on October 29, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 15 of 22 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 68%.
Following a +3.70% 3-day Advance, the price is estimated to grow further. Considering data from situations where MIR advanced for three days, in 232 of 326 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
The Aroon Indicator entered an Uptrend today. In 150 of 221 cases where MIR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 68%.
Bearish Trend Analysis
The 10-day RSI Indicator for MIR moved out of overbought territory on November 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In 19 of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at 63%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 60 of 68 cases where MIR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 88%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MIR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
MIR broke above its upper Bollinger Band on October 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 5 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 49 (best 1 - 100 worst), indicating steady price growth. MIR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 74, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 73 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.394) is normal, around the industry mean (3.805). MIR has a moderately high P/E Ratio (199.667) as compared to the industry average of (36.482). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.879). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (4.281) is also within normal values, averaging (186.943).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a blank check company, which engages in the merger capital stock exchange, asset acquisition, stock purchase, and reorganization.
Industry IndustrialMachinery